3rd Real World Evidence and Market Access

Organizer: Dynamic Global Events
Venue: Sonesta Philadelphia Rittenhouse Hotel | Philadelphia, PA, 1800 Market Street, Philadelphia, PA 19103, 19103 Philadelphia, United States
Website: go to
CME credits: available upon
Date: from: 2024-02-26 to: 2024-02-27
Fee: 1596 - 1996 EUR
Programme: view
Views: 421

RWE serves as a multifaceted tool, enhancing safety and efficacy data, demonstrating a product’s value and cost effectiveness to payers, and facilitating market entry for new and innovative treatments. In order to navigate the evolving landscape of RWE analysis, biopharma companies must gain insight into emerging clinical trial developments, cutting-edge AI trends, and the latest governmental regulations and policies.

DGE invites you to its 3rd Real World Evidence and Market Access Summit– the only industry event to specifically focus on discussing the current and future challenges associated with RWE utilization, all while illustrating its value in the ever-evolving healthcare landscape! Join us February 26-27 in Philadelphia for an unequaled learning opportunity about topics YOU requested – including:

Empower Regulatory Decisions with Real-World Evidence
Unlock RWE’s Impact in Single-Arm Clinical Trials
Navigate Increased Government Intervention in Trial Design
Enhance Reimbursement: RWE’s Influence on Drug Access and Pricing
Explore Healthcare Insights: AI and RWE Collaboration
Anticipate the Future of AI and Machine Learning

tags: RWE data analytics strategy HEOR medical affairs Medical Safety Market Access epidemiology Population Health Observational Research studies Post Approval drug Patient Safety Clinical Operations Development Medical scientific affairs Pricing Reimbursement commercialization Regulatory Affairs policy R& Real World Data and Evidence Trial Management Software Data Management Software Digital Platform Technology CROs Artificial Intelligence and Machine Learning

Past events

Top Events

Coming soon